DE3167210D1 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
DE3167210D1
DE3167210D1 DE8181106591T DE3167210T DE3167210D1 DE 3167210 D1 DE3167210 D1 DE 3167210D1 DE 8181106591 T DE8181106591 T DE 8181106591T DE 3167210 T DE3167210 T DE 3167210T DE 3167210 D1 DE3167210 D1 DE 3167210D1
Authority
DE
Germany
Prior art keywords
pharmacologically acceptable
compositions
pharmaceutical composition
pain
abscesses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181106591T
Other languages
English (en)
Inventor
Daniel W Stout
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3167210D1 publication Critical patent/DE3167210D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
DE8181106591T 1980-08-26 1981-08-25 Pharmaceutical composition Expired DE3167210D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/181,464 US4330551A (en) 1980-08-26 1980-08-26 Therapeutic method

Publications (1)

Publication Number Publication Date
DE3167210D1 true DE3167210D1 (en) 1984-12-20

Family

ID=22664383

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181106591T Expired DE3167210D1 (en) 1980-08-26 1981-08-25 Pharmaceutical composition

Country Status (6)

Country Link
US (1) US4330551A (de)
EP (1) EP0046594B1 (de)
JP (1) JPS57118514A (de)
AT (1) ATE10255T1 (de)
CA (1) CA1179604A (de)
DE (1) DE3167210D1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3341569A1 (de) * 1983-11-17 1985-05-30 Helmut Dr.med. 2000 Hamburg Opel Oberflaechenanalgetikum und -antiphlogistikum
JPS61502124A (ja) * 1984-05-09 1986-09-25 ジ　オ−ストラリアン　ナシヨナル　ユニヴア−シテイ− 免疫応答の調節方法
DE3880923T3 (de) * 1987-02-23 1997-12-18 Shiseido Co Ltd Perkutaner absorptionspromotor und dermatologische zusammensetzung für externe anwendung.
FR2628319B1 (fr) * 1988-03-09 1990-12-07 Oreal Compositions pharmaceutiques et cosmetiques a base de peroxyde de benzoyle et de sels d'ammonium quaternaires
US5545667A (en) * 1991-04-26 1996-08-13 The Clorox Company Methods for treating neoplasms with betaines
FR2699404B1 (fr) * 1992-12-18 1995-01-27 Oreal Composition cosmétique ou dermatologique biphase pour le démaquillage, le nettoyage ou le soin de la peau contenant du chlorure de benzalkonium.
FR2715300B1 (fr) * 1994-01-24 1996-03-29 Aromafarm Ltd Solution injectable de fluorure de benzalkonium et application à titre d'antiviral ou d'anti-infectieux.
AU4972599A (en) 1998-07-07 2000-01-24 Transdermal Technologies, Inc. Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof
KR100579717B1 (ko) * 1998-12-03 2006-09-27 주식회사 엘지생활건강 양이온성 당류계 계면활성제 및 그의 제조 방법
US20060121103A1 (en) * 2000-05-11 2006-06-08 Kenneth Kirby Transdermal delivery system
CA2936453A1 (en) 2014-01-09 2015-07-16 Axiosonic, Llc Systems and methods using ultrasound for treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2293748A (en) * 1941-10-29 1942-08-25 William J Johnson Magnetic brake
US2361236A (en) * 1942-12-30 1944-10-24 Preece David Rupert Transplanter
GB635116A (en) * 1947-03-19 1950-04-05 Johan Alfred Holm A device for the automatic braking of reels for fishing rods
US2739097A (en) * 1951-10-31 1956-03-20 Norwich Pharma Co Composition for the treatment of demodectic mange
FR2839M (fr) * 1963-05-17 1964-10-12 Guy Médicament nouveau pour la thérapeutique des oedemes localisés et des cicatrisations des muqueuses.
FR5414M (de) * 1966-03-02 1967-10-02
FR1489793A (fr) * 1966-06-13 1967-07-28 Ile De Marques Et Brevets Soc Excipient perfectionné pour produits cosmétologiques et produits comportant cet excipient
US3624224A (en) * 1969-12-22 1971-11-30 Schering Corp Novel first aid products
JPS5491490A (en) * 1977-12-29 1979-07-19 Rokurou Matsushima Brake apparatus of fishing reel

Also Published As

Publication number Publication date
EP0046594A3 (en) 1982-04-14
CA1179604A (en) 1984-12-18
JPS57118514A (en) 1982-07-23
JPH0150682B2 (de) 1989-10-31
ATE10255T1 (de) 1984-11-15
US4330551A (en) 1982-05-18
EP0046594B1 (de) 1984-11-14
EP0046594A2 (de) 1982-03-03

Similar Documents

Publication Publication Date Title
DE3851152D1 (de) Cyclosporin-augenmittel.
MX9304530A (es) Suministro topico mejorado de farmacos.
IL111365A (en) (R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans their preparation and pharmaceutical compositions containing them
MX9703429A (es) Composiciones hermorroidales y metodos de uso.
DE3167210D1 (en) Pharmaceutical composition
CA2186380A1 (en) Novel carbamates and ureas as modifiers of multi-drug resistance
ES8506616A1 (es) Un procedimiento para la preparacion de carboxamidas
ES8303092A1 (es) Procedimiento para la obtencion de lapices antimicoticos con mayor liberacion de sustancia activa.
EP0667160A3 (de) Anwendung von Prostagrandin-Analogen für die Behandlung von Glaukome und okuläre Hypertension.
FR2453648A1 (fr) Nouvelles compositions pharmaceutiques a base d'une quinazolinone exercant une action analgesique et d'un agent myotonolytique
ES8307493A1 (es) Procedimiento para preparar una crema grasa terapeutica de rapida absorcion por la piel.
DE3369343D1 (en) Detergent compositions
FR2434804A1 (fr) Derives de la n-phenyl-indoline, leur preparation et leur application comme medicaments
JPS5750914A (en) Betamethasone external pharmaceutical
BE901340A (fr) Compositions pour le traitement de la chevelure.
ES468750A1 (es) Un metodo para preparar una composicion veterinaria que com-prende trimetoprim y sulfaquinoxalina
MX174139B (es) Composiciones y metodo para tratamiento de glaucoma por la administracion topica de t-butilamino-3-(4-morfolin-1,2,5-tiadiazol-3-iloxi-2-propanol,hidrogeno maleato
GR3018349T3 (en) Use of naproxen as mydriatic agent.
SG13094G (en) Stabilization of the preservative thiomersal in ophthalmic pharmaceutical compositions.

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee